“Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody”, A. LiewC. Baustian, D. Thomas, E. VaughanC. Sanz-NoguésM. CreaneX. ChenS. AlagesanP. OwensJ. HoranP. DockeryM. D. GriffinA. DuffyT. O’Brien. Cell Transplant. 2018 Aug;27(8):1210-1221. DOI: 10.1177/0963689718784862. Epub 2018 Jul 17. Download the pdf here.

“Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England”, N.T.Q. Nguyen, P. Cockwell, A.P. Maxwell, M. Griffin, T. O’Brien, C. O’Neill. PLoS One. 2018 Nov 26;13(11):e0207960. DOI: 10.1371/journal.pone.0207960. eCollection 2018. PubMed PMID: 30475893; PubMed Central PMCID: PMC6258125. Download the pdf here.

“Effect of Sodium Glucose Co-Transporter-2 Inhibition on the Aldosterone/Renin Ratio in Type 2 Diabetes Mellitus”, Griffin TP, Islam MN, Blake L, Bell M, Griffin MD, O’Shea PM. Horm Metab Res 2019; 51:91-99. DOI: 10.1055/a-0794-7026. Epub 2019 Dec 6, after which, full text is available here.

“Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology”, Norberto Perico, Federica Casiraghi, Giuseppe Remuzzi, Journal of the American Society of Nephrology, 29/2, Lippincott Williams & Wilkins Ltd. USA, 2018. DOI: 10.1681/ASN.2017070781 Download the pdf here.

“Interspecies Incompatibilities Limit the Immunomodulatory Effect of Human Mesenchymal Stromal Cells in the Rat”, Paul Lohan, Oliver Treacy, Maurice Morcos, Ellen Donohoe, Yvonne O’donoghue, Aideen E. Ryan, Stephen J. Elliman, Thomas Ritter, Matthew D. Griffin, STEM CELLS, AlphaMed Press Inc, USA, 2018. DOI: 10.1002/stem.2840 Download the pdf here.

“Mesenchymal Stromal Cells for AKI after Cardiac Surgery”, Norberto Perico, Federica Casiraghi, Giuseppe Remuzzi, Journal of the American Society of Nephrology, Lippincott Williams & Wilkins Ltd. USA, 2018. DOI: 10.1681/ASN.2017111207 Download the pdf here.

“Phenotypic and functional heterogeneity of human intermediate monocytes based on HLA-DR expression”, Eanna P Connaughton, Serika Naicker, Shirley A Hanley, Stephanie M Slevin, John K Eykelenboom, Noel F Lowndes, Timothy O’Brien, Rhodri Ceredig, Matthew D Griffin, Michael C Dennedy, Immunology and Cell Biology, pp 536-548, Blackwell Publishing Inc., UK, 2018. DOI: 10.1111/imcb.12032  Full text available here.

“Anti-donor antibody induction following intramuscular injections of allogeneic mesenchymal stromal cells”, Senthilkumar Alagesan, Clara Sanz- Nogués, Xizhe Chen, Michael Creane, Thomas Ritter, Rhodri Ceredig, Timothy O’Brien, Matthew D Griffin, Immunology and Cell Biology, 96/5, Blackwell Publishing, Inc., UK, 2018. DOI: 10.1111/imcb.12024  Full text available here.

“Hyperactivation of nuclear receptor coactivators induces PERK-dependent cell death”, Muhammad Mosaraf Hossain, David Barua, Vahid Arabkari, Nahidul Islam, Ananya Gupta, Sanjeev Gupta, Oncotarget, 9/14, Impact Journals, USA, 2018. DOI: 10.18632/oncotarget.24451 Download the pdf here.

“Chronic kidney disease”, Paola Romagnani, Giuseppe Remuzzi, Richard Glassock, Adeera Levin, Kitty J. Jager, Marcello Tonelli, Ziad Massy, Christoph Wanner, Hans- Joachim Anders, Nature Reviews Disease Primers, 3, online, 2017. DOI: 10.1038/nrdp.2017.88  Full text available here.

“Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?”, Paul Lohan, Oliver Treacy, Matthew D. Griffin, Thomas Ritter, Aideen E. Ryan, Frontiers in Immunology, 8, online, 2017. DOI: 10.3389/fimmu.2017.01626 Download the pdf here.

“Influence of Referral to a Combined Diabetology and Nephrology Clinic on Renal Functional Trends and Metabolic Parameters in Adults With Diabetic Kidney Disease”, William P. Martin, Tomás P. Griffin, David W. Lappin, Damian G. Griffin, John P. Ferguson, Timothy O’Brien, Matthew D. Griffin, Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 1/2, pp 150-160, Elsevier, New York, 2017. DOI: 10.1016/j.mayocpiqo.2017.07.003 Download the pdf here.

“The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease”, Tomás P. Griffin, William Patrick Martin, Nahidul Islam, Timothy O’BrienMatthew D. Griffin, Current Diabetes Reports,16:42, Springer, U.S., May 2016. DOI: 10.1007/s11892-016-0734-6 Full text available here.

“The Immune System in Tissue Environments Regaining Homeostasis after Injury: Is “Inflammation” Always Inflammation?”, Onkar P. Kulkarni, Julia Lichtnekert, Hans- Joachim Anders, Shrikant R. Mulay, Mediators of Inflammation, pp 1-9, Hindawi Publishing, Egypt, 2016. DOI: 10.1155/2016/2856213 Download the pdf here.

“Defining reference intervals for a serum growth differentiation factor-15 (GDF-15) assay in a Caucasian population and its potential utility in diabetic kidney disease (DKD)”, Siobhan M. Hamon, Tomás P. Griffin, Md Nahidul Islam, Deirdre Wall, Matthew D. Griffin, Paula M. O’Shea, Clinical Chemistry and Laboratory Medicine (CCLM), 20180534, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, Walter de Gruyter GmbH, Berlin/Boston, 2018, DOI: https://doi.org/10.1515/cclm-2018-0534. After 15 September 2019, the full text is available here.

“Mesenchymal stromal cells for Transplant Tolerance”, Manuel Alfredo Podestà, Giuseppe Remuzzi, and Federica Casiraghi, Frontiers in Immunology, 10:1287, 4 June 2019, DOI: 10.3389/fimmu.2019.01287  Download the pdf here.

“Human mesenchymal stromal cells broadly modulate high glucose-induced inflammatory responses of renal proximal tubular cell monolayers”, Md Nahidul Islam, Tomás P. Griffin, Elizabeth Sander, Stephanie Rocks, Junaid Qazi, Joana Cabral, Jasmin McCaul, Tara McMorrow and Matthew D. Griffin, Stem Cell Research & Therapy (2019) 10:329, DOI: 10.1186/s13287-019-1424-5 Download the pdf here.